Oliver Goodyear

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Oliver Goodyear, Mike Dennis, Nadira Jilani et al. · Blood · 2012 · 393 citations

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky‐Basso et al. · Blood · 2010 · 334 citations · Full text

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

Mark Cobbold, Hugo De La Peña, Andrew J. Norris et al. · Science Translational Medicine · 2013 · 202 citations

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Charles Craddock, Nadira Jilani, Shamyla Siddique et al. · Biology of Blood and Marrow Transplantation · 2015 · 173 citations · Full text

Ricaza Trial, Cell Therapy, Transplantation Medicine +22

Fetal-Specific CD8+ Cytotoxic T Cell Responses Develop during Normal Human Pregnancy and Exhibit Broad Functional Capacity

D. Lissauer, Karen Piper Hanley, Oliver Goodyear et al. · The Journal of Immunology · 2012 · 131 citations

Semiallogeneic Fetus, Lymphocyte Development, Adaptive Immune System +26